Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey

Abstract

Aims:

To determine the monitoring and treatment of neonatal abstinence syndrome (NAS) in neonatal intensive care units (NICUs) following opiate or polydrug exposure in utero.

Methods:

A pretested questionnaire was distributed via email to the chiefs of the neonatology divisions with accredited Fellowship programs in Neonatal-Perinatal Medicine in the United States.

Results:

Of the 102 individuals contacted, 75 participated in the survey. In all, 41 of the respondents (54.5%) have a written policy regarding the management of neonatal NAS. The method of Finnegan is the most commonly used abstinence scoring system (49 of 75, 65%), while only three respondents use the Lipsitz tool. Opioids (tincture of opium, or morphine sulfate solution) are used most commonly for management of both opioid (63% of respondents) and polydrug (52% of respondents) withdrawal, followed by phenobarbital (32 % of respondents) for polydrug withdrawal and methadone (20% of respondents) for opioid withdrawal. In all, 53 respondents (70%) use phenobarbital, and 19 (25%) use intravenous morphine to control opioid withdrawal seizures, while 61 (81%) use phenobarbital in cases of polydrug withdrawal seizures. Only 53 respondents (70%) always use an abstinence scoring system to determine when to start, titrate, or terminate pharmacologic treatment of neonatal NAS.

Conclusion:

The management of neonatal psychomotor behavior consistent with withdrawal varies widely, with inconsistent policies to determine its presence or treatment. Only about half of NICUs have written guidelines for the management of NAS, which may preclude effective auditing of this practice. Educational interventions may be necessary to ensure changes in clinical practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Preliminary Results From the 1996 National Household Survey on Drug Abuse. US Dept of Health and Human Services: Washington, DC August 1997.

  2. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079–1088.

  3. Bodenheimer T . The American health care system. The movement for improved quality in health care. N Engl J Med 1999; 340: 488–492.

    Article  CAS  Google Scholar 

  4. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R . Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977; 127: 199–201.

    Article  CAS  Google Scholar 

  5. Ostrea EM, Chavez CJ, Strauss ME . A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976; 88: 642–645.

    Article  CAS  Google Scholar 

  6. Lipsitz PJA . Proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr 1975; 14: 592–594.

    Article  CAS  Google Scholar 

  7. Finnegan LP, Kron RE, Connaughton JF, Emich JP . Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm 1975; 12: 19–32.

    CAS  PubMed  Google Scholar 

  8. Morrison CL, Siney C . A survey of the management of neonatal opiate withdrawal in England and Wales. Eur J Pediatr 1996; 155: 323–326.

    Article  CAS  Google Scholar 

  9. Micard S, Brion F . Management of the opioid withdrawal in the neonates: French and European survey. Arch Pediatr 2003; 10: 199–203.

    Article  CAS  Google Scholar 

  10. Ambalavanan N, Kennedy K, Tyson J, Carlo WA . Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence? J Pediatr 2004; 145: 304–307.

    Article  CAS  Google Scholar 

  11. Leviton LC, Orleans CT . Promoting the uptake of evidence in clinical practice: a prescription for action. Clin Perinatol 2003; 30: 403–417.

    Article  Google Scholar 

  12. Grol R . Implementation of evidence and guidelines in clinical practice: a new field of research? Int J Qual Health Care 2000; 12: 455–456.

    Article  CAS  Google Scholar 

  13. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA . Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings: the Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998; 317: 465–468.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Sarkar.

Additional information

Supplementary Information accompanies the paper on the Journal of Perinatology website (http://www.nature.com/jp).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarkar, S., Donn, S. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 26, 15–17 (2006). https://doi.org/10.1038/sj.jp.7211427

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211427

Keywords

This article is cited by

Search

Quick links